scholarly journals European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC

2017 ◽  
Vol 31 (12) ◽  
pp. 1951-1963 ◽  
Author(s):  
A. Nast ◽  
P.I. Spuls ◽  
G. van der Kraaij ◽  
P. Gisondi ◽  
C. Paul ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Systemic Treatment ◽  
S3 Guideline

S3 Guideline for the treatment of psoriasis vulgaris, update – Short version part 1 – Systemic treatment

2018 ◽  
Vol 16 (5) ◽  
pp. 645-669 ◽  
Author(s):  
Alexander Nast ◽  
Lasse Amelunxen ◽  
Matthias Augustin ◽  
Wolf‐­Henning Boehncke ◽  
Corinna Dressler ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Systemic Treatment ◽  
Short Version ◽  
S3 Guideline

scholarly journals German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 2: Treatment monitoring and specific clinical or comorbid situations

2021 ◽  
Vol 19 (7) ◽  
pp. 1092-1115
Author(s):  
Alexander Nast ◽  
Andreas Altenburg ◽  
Matthias Augustin ◽  
Wolf‐Henning Boehncke ◽  
Peter Härle ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Treatment Monitoring ◽  
S3 Guideline

scholarly journals German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 1: Treatment goals and treatment recommendations

2021 ◽  
Vol 19 (6) ◽  
pp. 934-150
Author(s):  
Alexander Nast ◽  
Andreas Altenburg ◽  
Matthias Augustin ◽  
Wolf‐Henning Boehncke ◽  
Peter Härle ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Treatment Recommendations ◽  
Treatment Goals ◽  
S3 Guideline

scholarly journals EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations

2020 ◽  
Vol 34 (11) ◽  
pp. 2461-2498
Author(s):  
A. Nast ◽  
C. Smith ◽  
P.I. Spuls ◽  
G. Avila Valle ◽  
Z. Bata‐Csörgö ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Systemic Treatment

scholarly journals EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations

2021 ◽  
Vol 35 (2) ◽  
pp. 281-317
Author(s):  
A. Nast ◽  
C. Smith ◽  
P.I. Spuls ◽  
G. Avila Valle ◽  
Z. Bata‐Csörgö ◽  
...  
Keyword(s):  
Psoriasis Vulgaris ◽  
Systemic Treatment

HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study

2014 ◽  
Vol 27 (5) ◽  
pp. 284-289 ◽  
Author(s):  
Alessandro Borghi ◽  
Roberta Rizzo ◽  
Monica Corazza ◽  
Alberto Maria Bertoldi ◽  
Daria Bortolotti ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Treatment Response ◽  
Psoriasis Vulgaris ◽  
Systemic Treatment ◽  
Preliminary Results ◽  
G 14

Methods Report: Update of the German S3 Guideline for the Treatment of Psoriasis vulgaris

2018 ◽  
Vol 16 (5) ◽  
Author(s):  
Matthew Gaskins ◽  
Corinna Dressler ◽  
Ricardo Niklas Werner ◽  
Alexander Nast
Keyword(s):  
Psoriasis Vulgaris ◽  
S3 Guideline

Topical treatment of chronic dermatoses with kertoplastic agents

2016 ◽  
Vol 19 (3) ◽  
pp. 170-172
Author(s):  
O. V Grabovskaya ◽  
E. Yu Vertieva ◽  
L. A Shestakova ◽  
Ekaterina V. Grekova
Keyword(s):  
Atopic Dermatitis ◽  
Topical Treatment ◽  
Psoriasis Vulgaris ◽  
Skin Diseases ◽  
Systemic Treatment ◽  
Skin Condition ◽  
Results Of Treatment ◽  
Severity Of The Disease

Atopic dermatitis and psoriasis are common chronic dermatosis characterized by prolonged recurrent course. Depending on the severity of the disease topical and systemic treatment are applied. Keratoplastic agents play an important role in treatment of skin diseases. These agents include Naftalan Cream 30%, which significantly improves the skin condition. The results of treatment of 10 patients with atopic dermatitis and 10 patients with psoriasis vulgaris Naftalan cream 30% are presented.

Sign in / Sign up

Export Citation Format

Share Document